Your browser doesn't support javascript.
A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients.
Valerio Pascua, Fernando; Diaz, Oscar; Medina, Rina; Contreras, Brian; Mistroff, Jeff; Espinosa, Daniel; Sekhon, Anupamjeet; Paz Handal, Diego; Pineda, Estela; Vargas Pineda, Miguel; Pineda, Hector; Diaz, Maribel; Lewis, Anita S; Hesse, Heike; Castro Lainez, Miriams T; Stevens, Mark L; Sierra-Hoffman, Miguel; Ontai, Sidney C; VanBuren, Vincent.
  • Valerio Pascua F; Department of Critical Care Hospital Leonardo Martínez, San Pedro Sula, Cortés, Honduras.
  • Diaz O; Department of Critical Care Hospital Regional del Norte Instituto Hondureño de Seguridad Social, San Pedro Sula, Cortés, Honduras.
  • Medina R; Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
  • Contreras B; Detar Family Medicine Residency Program, Texas A&M College of Medicine Victoria, Victoria, TX, United States of America.
  • Mistroff J; Detar Family Medicine Residency Program, Texas A&M College of Medicine Victoria, Victoria, TX, United States of America.
  • Espinosa D; Victoria Hospitalist Associates, Detar Hospital, Victoria, TX, United States of America.
  • Sekhon A; Detar Family Medicine Residency Program, Texas A&M College of Medicine, Victoria, TX, United States of America.
  • Paz Handal D; Universidad Nacional Autónoma de Honduras, San Pedro Sula, Cortés, Honduras.
  • Pineda E; Hospital Leonardo Martínez, San Pedro Sula, Cortés, Honduras.
  • Vargas Pineda M; Hospital Leonardo Martínez, San Pedro Sula, Cortés, Honduras.
  • Pineda H; Department of Neurology, Hospital Mario Catarino Rivas, San Pedro Sula, Cortés, Honduras.
  • Diaz M; Department of Allergy and Immunology, Instituto Hondureño de Seguridad Social, Sociedad Hondureña de Inmunología, Tegucigalpa, Honduras.
  • Lewis AS; Pharmacy Department, El Campo Memorial Hospital, El Campo, TX, United States of America.
  • Hesse H; Neurology Department, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
  • Castro Lainez MT; Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
  • Stevens ML; Research Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States of America.
  • Sierra-Hoffman M; Research and Infectious Disease Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States of America.
  • Ontai SC; Detar Family Medicine Residency Program Department, Texas A&M University College of Medicine, Victoria, TX, United States of America.
  • VanBuren V; Round Rock Clinical Campus, Texas A&M College of Medicine, Round Rock, TX, United States of America.
PLoS One ; 16(1): e0245025, 2021.
Article in English | MEDLINE | ID: covidwho-1060203
ABSTRACT

PURPOSE:

COVID-19 pandemic has multifaceted presentations with rising evidence of immune-mediated mechanisms underplay. We sought to explore the outcomes of severe COVID-19 patients treated with a multi-mechanism approach (MMA) in addition to standard-of-care (SC) versus patients who only received SC treatment. MATERIALS AND

METHODS:

Data were collected retrospectively for patients admitted to the intensive care unit (ICU). This observational cohort study was performed at five institutions, 3 in the United States and 2 in Honduras. Patients were stratified for MMA vs. SC treatment during ICU stay. MMA treatment consists of widely available medications started immediately upon hospitalization. These interventions target immunomodulation, anticoagulation, viral suppression, and oxygenation. Primary outcomes included in-hospital mortality and length of stay (LOS) for the index hospitalization and were measured using logistic regression.

RESULTS:

Of 86 patients admitted, 65 (76%) who had severe COVID-19 were included in the study; 30 (46%) patients were in SC group, compared with 35 (54%) patients treated with MMA group. Twelve (40%) patients in the SC group died, compared with 5 (14%) in the MMA group (p-value = 0.01, Chi squared test). After adjustment for gender, age, treatment group, Q-SOFA score, the MMA group had a mean length of stay 8.15 days, when compared with SC group with 13.55 days. ICU length of stay was reduced by a mean of 5.4 days (adjusted for a mean age of 54 years, p-value 0.03) and up to 9 days (unadjusted for mean age), with no significant reduction in overall adjusted mortality rate, where the strongest predictor of mortality was the use of mechanical ventilation.

CONCLUSION:

The finding that MMA decreases the average ICU length of stay by 5.4 days and up to 9 days in older patients suggests that implementation of this treatment protocol could allow a healthcare system to manage 60% more COVID-19 patients with the same number of ICU beds.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Intensive Care Units / Length of Stay Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Central America / Honduras Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0245025

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Intensive Care Units / Length of Stay Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Central America / Honduras Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0245025